[Page 8 of 9 Joint Filing Agreement [Remainder of this page has been left intentionally blank.] Page 9 of 9 Bin Li Bin Li Proudview Limited Bin Li Director EX-99.(A) 2 d299225dex99a.htm JOINT FILING AGREEMENT] [Page 2 of 9]
[1 2 Page 1 of 12 CUSIP No. 50047P104 1. Names of Reporting Persons IDG-Accel China Growth Fund II L.P. 2.]
[Joint Filing Agreement Dated: February 13, 2012 TRUSTBRIDGE PARTNERS III, L.P. Shujun Li Authorized Representative TB PARTNERS GP3, L.P. Shujun Li Authorized Representative TB PARTNERS GP LIMITED Shujun Li Authorized Representative TB ALTERNATIVE ASSETS LTD. Shujun Li Authorized Representative EX-99.(A) 2 d301539dex99a.htm JOINT FILING AGREEMENT] [SCHEDULE 13G CUSIP No. 74734M109 Page 2 of 9 Pages 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Trustbridge Partners III, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ x (a) 3 SEC USE ONLY]
[CUSIP No. 16950M17 1 NAMES OF REPORTING PERSONS Investor AB 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (b) [ ] 3 S EC USE ONLY 4]
[Page 8 of 9 Joint Filing Agreement [Remainder of this page has been left intentionally blank.] Page 9 of 9 Bin Li Bin Li Proudview Limited Bin Li Director EX-99.(A) 2 d299225dex99a.htm JOINT FILING AGREEMENT] [Page 2 of 9]
[USIP O C 13G Page 2 of 13 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OFOVE PERSONmmonwealth Bank of Australia 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A x (a) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Australianpital Territory,mmonwealth of Australia] [USIP O C 13G Page 12 of 13 Joint Filingreement February , 2012 Thisreement may be executed in multipleunterparts, each of which shallnstitute an original, one and theme instrument.mmonwealth Bank of Australia Johnmien Hattonmpany Secretarylonialmpany Limited Johnmien Hatton Director] [USIP O C 13G Page 13 of 13 Item7 Information The securities being reported on by the reporting persons herein parentmpanies are owned, or may be deemed to be beneficially owned follows:mpany Type ofmpany . First State Investments (Hong Kong) Limited IA (HK registered) First State Investments International]
[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 February 13, 2012 VIA EDGAR Division ofrporation Finance 100 F Street, NE Mail Stop: 3561 Attention:Jim B. Rosenberg, Seniorsistant Chief Accountant Re: China Pharmas, Form 10-K for the Fiscal Year Ended December 31, 2010]
[1 2 Page 1 of 12 CUSIP No. 50047P104 1. Names of Reporting Persons IDG-Accel China Growth Fund II L.P. 2.]
[Joint Filing Agreement Dated: February 13, 2012 TRUSTBRIDGE PARTNERS III, L.P. Shujun Li Authorized Representative TB PARTNERS GP3, L.P. Shujun Li Authorized Representative TB PARTNERS GP LIMITED Shujun Li Authorized Representative TB ALTERNATIVE ASSETS LTD. Shujun Li Authorized Representative EX-99.(A) 2 d301539dex99a.htm JOINT FILING AGREEMENT] [SCHEDULE 13G CUSIP No. 74734M109 Page 2 of 9 Pages 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Trustbridge Partners III, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP ¨ x (a) 3 SEC USE ONLY]
[FORM 10-Q (Mark One) x For the quarterly period ended December 31, 2011 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2011 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2011 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director]
